Related Experiment Video
Updated: Aug 2, 2026

A Strategy to Identify Compounds that Affect Cell Growth and Survival in Cultured Mammalian Cells at Low-to-Moderate Throughput
Published on: September 22, 2019
Do we find relevant parameters for in vitro cytotoxicity testing?
1Cell Lab, Behavioral Biology, Federal Institute of Technology, ETH-Center, Zurich, Switzerland.
Abstract:
The current strategy for the design of cytotoxicity tests is briefly reviewed in light of goals that need to be reached, and in the capacity of in vitro tests to fulfill the high public expectations for alternative methods to animal testing. Various cytotoxicity tests and parameters used for the assessment of topical toxicity and of neurotoxicity are chosen as examples and their relevance is discussed. Past experience with in vitro and short-term tests for mutagenicity shows not to look for one single supertest. A proposition for reasonable safety testing implies that a combined approach must be developed that integrates the results from a battery of cell tests and from structure-activity analyses as well as from kinetic and metabolic studies. The relevance of such an integrated approach must be aimed directly at the organisms that may be exposed.
Insights
Developing effective in vitro cytotoxicity tests requires an integrated approach, combining cell-based assays and structure-activity analyses to meet public demand for alternatives to animal testing.
Area of Science:
- Toxicology
- In vitro toxicology
- Alternative testing methods
Background:
- Current cytotoxicity test strategies are reviewed against the need for reliable in vitro alternatives to animal testing.
- Public expectations for non-animal testing methods are high.
- Existing in vitro and short-term mutagenicity tests highlight the limitations of a single 'supertest' approach.
Purpose of the Study:
- To review the current strategy for designing cytotoxicity tests.
- To discuss the relevance of various in vitro tests for topical and neurotoxicity assessment.
- To propose an integrated approach for safety testing that aligns with public expectations and scientific rigor.
Main Methods:
- Review of current cytotoxicity testing strategies.
- Discussion of specific in vitro tests for topical and neurotoxicity.
- Analysis of past experiences with in vitro mutagenicity testing.
- Proposal for an integrated safety testing framework.
Main Results:
- A single 'supertest' is insufficient for comprehensive safety assessment.
- Various cytotoxicity tests have limitations when assessed in isolation.
- An integrated approach is necessary to fulfill the goals of alternative testing.
Conclusions:
- Effective in vitro safety testing necessitates a combined strategy.
- Integrating results from cell-based assays, structure-activity analyses, and kinetic/metabolic studies is crucial.
- The relevance of integrated approaches should be evaluated based on the organisms potentially exposed.

